BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34482820)

  • 1. Absolute quantitative proteomics using the total protein approach to identify novel clinical immunohistochemical markers in renal neoplasms.
    Jorge S; Capelo JL; LaFramboise W; Satturwar S; Korentzelos D; Bastacky S; Quiroga-Garza G; Dhir R; Wiśniewski JR; Lodeiro C; Santos HM
    BMC Med; 2021 Sep; 19(1):196. PubMed ID: 34482820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-7 and claudin-8: immunohistochemical markers for the differential diagnosis of chromophobe renal cell carcinoma and renal oncocytoma.
    Osunkoya AO; Cohen C; Lawson D; Picken MM; Amin MB; Young AN
    Hum Pathol; 2009 Feb; 40(2):206-10. PubMed ID: 18799195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the clear cell renal cell carcinoma proteome.
    Morgan TM; Seeley EH; Fadare O; Caprioli RM; Clark PE
    J Urol; 2013 Mar; 189(3):1097-103. PubMed ID: 23009866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonic-assisted extraction and digestion of proteins from solid biopsies followed by peptide sequential extraction hyphenated to MALDI-based profiling holds the promise of distinguishing renal oncocytoma from chromophobe renal cell carcinoma.
    Jorge S; Pereira K; López-Fernández H; LaFramboise W; Dhir R; Fernández-Lodeiro J; Lodeiro C; Santos HM; Capelo-Martínez JL
    Talanta; 2020 Jan; 206():120180. PubMed ID: 31514886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
    Tan MH; Wong CF; Tan HL; Yang XJ; Ditlev J; Matsuda D; Khoo SK; Sugimura J; Fujioka T; Furge KA; Kort E; Giraud S; Ferlicot S; Vielh P; Amsellem-Ouazana D; Debré B; Flam T; Thiounn N; Zerbib M; Benoît G; Droupy S; Molinié V; Vieillefond A; Tan PH; Richard S; Teh BT
    BMC Cancer; 2010 May; 10():196. PubMed ID: 20462447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study.
    Rocca PC; Brunelli M; Gobbo S; Eccher A; Bragantini E; Mina MM; Ficarra V; Zattoni F; Zamò A; Pea M; Scarpa A; Chilosi M; Menestrina F; Bonetti F; Eble JN; Martignoni G
    Mod Pathol; 2007 Jul; 20(7):722-8. PubMed ID: 17483815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical diagnosis of renal neoplasms.
    Truong LD; Shen SS
    Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amylase α-1A (AMY1A): a novel immunohistochemical marker to differentiate chromophobe renal cell carcinoma from benign oncocytoma.
    Jain S; Roy S; Amin M; Acquafondata M; Yin M; Laframboise W; Bastacky S; Pantanowitz L; Dhir R; Parwani A
    Am J Surg Pathol; 2013 Dec; 37(12):1824-30. PubMed ID: 24225843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
    Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
    Atrih A; Mudaliar MA; Zakikhani P; Lamont DJ; Huang JT; Bray SE; Barton G; Fleming S; Nabi G
    Br J Cancer; 2014 Mar; 110(6):1622-33. PubMed ID: 24548857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues.
    Zhang J; Li SQ; Lin JQ; Yu W; Eberlin LS
    Cancer Res; 2020 Feb; 80(4):689-698. PubMed ID: 31843980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.
    Liu L; Qian J; Singh H; Meiers I; Zhou X; Bostwick DG
    Arch Pathol Lab Med; 2007 Aug; 131(8):1290-7. PubMed ID: 17683191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of chromophobe renal cell carcinoma and benign renal oncocytoma biopsies reveals shared metabolic dysregulation.
    Carvalho LB; Jorge S; López-Fernández H; Lodeiro C; Dhir R; Campos Pinheiro L; Medeiros M; Santos HM; Capelo JL
    Clin Proteomics; 2023 Nov; 20(1):54. PubMed ID: 38017382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
    Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
    Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.